SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

CBE Cobre Limited

Basic Materials · Other Industrial Metals & Mining · website
$0.34
52wk 0.07 – 0.43
Overall
72.5
Value
71.4
Growth
92.9
Health
100.0
Quality
0.0
Momentum
82.9
Dividend
—
Price
About Cobre Limited

Cobre Limited engages in the exploration and evaluation of mineral properties in Australia and Botswana. It explores for copper, gold, silver, and zinc deposits. The company's flagship project is the 100% owned Ngami Copper Project covering an area of 727 square kilometers located in Botswana. Cobre Limited was incorporated in 2018 and is based in Sydney, Australia.

Commodity exposure

Primary exposure: Copper (detected from the company profile: copper)

Copper primary
6.58 USD/lb
1m: 1.3% · 1y: 34.4%
Gold
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Silver
61.52 USD/oz
1m: -4.9% · 1y: 33.7%
Zinc
No direct price series on Yahoo Finance
Price analytics

Returns

1 day -6.8%
1 week -8.0%
1 month -11.5%
3 months 4.5%
6 months 115.6%
1 year 392.9%
3 years 604.1%

Risk

Volatility (1y ann.) 111.1%
Beta vs ASX 200 2.58
Sharpe (1y) 1.94
VaR 95% (1-day) -9.4%
Max drawdown (1y) -40.0%
Off 1-year high -18.8%

Technicals

RSI(14) 54
vs 50DMA -1.3%
vs 200DMA 40.7%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 71.4
Trailing P/E
—
Forward P/E
98
PEG ratio
—
EV / EBITDA
100
Price / Book
51
Price / Sales
0
Growth 92.9
Revenue growth (1y)
93
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 82.9
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
43
Position in 52-week range
76

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$426.27M
P/E (trailing)
—
P/E (forward)
8.62
EPS (trailing)
-0.03
Dividend yield
—
Payout ratio
0.0%
Beta
—
EV / EBITDA
-17.59
Price / Book
4.31
ROE
-23.7%
Operating margin
-4,232.0%
Net margin
0.0%
Total cash
$19.76M
Total debt
$0
Current ratio
2.57
Debt / Equity
—
Free cash flow
$-7.02M
Avg volume
5.15M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue—
  • Gross profit—
  • Operating income-$2.48M
  • Net income-$2.12M
  • Diluted EPS-0.01
  • Free cash flow-$7.78M
  • Net debt$878.62K
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6